Alcohol-associated liver disease
Open accessThe DOI matches its Crossref record; 199 of the 202 references it cites were found in a registry or an index.
Abstract
Alcohol-associated liver disease (ALD) is a major cause of chronic liver disease worldwide, and comprises a spectrum of several different disorders, including simple steatosis, steatohepatitis, cirrhosis, and superimposed hepatocellular carcinoma. Although tremendous progress has been made in the field of ALD over the last 20 years, the pathogenesis of ALD remains obscure, and there are currently no FDA-approved drugs for the treatment of ALD. In this Review, we discuss new insights into the pathogenesis and therapeutic targets of ALD, utilizing the study of multiomics and other cutting-edge approaches. The potential translation of these studies into clinical practice and therapy is deliberated. We also discuss preclinical models of ALD, interplay of ALD and metabolic dysfunction, alcohol-associated liver cancer, the heterogeneity of ALD, and some potential translational research prospects for ALD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In ALD, hepatocyte cell death results in the release of DAMPs that, together with gut-derived PAMPs, activate surrounding immune cells and serve as recruiting signals for circulating immune cells [82, 83].”
From Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells (2025) · doi:10.1038/s41423-025-01313-7 · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100 · cited 1×
“…liver disease, which encompasses all types of fatty liver diseases, now termed MASLD, which replaces the stig-matizing “nonalcoholic fatty liver disease” (NAFLD), and a new category, called MetALD, which includes patients with MASLD who also have significant alcohol consumption (143, 144).”
Global burden of liver disease: 2023 update
Devarbhavi, H., Asrani, S. K., Arab, J. P., Nartey, Y. A., Pose, E., & Kamath, P. S. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.03.017 · Cited by 2,267
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Self-citationResolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 1×
“Indeed, by utilizing scRNA-Seq analysis, two studies have identified new cell subpopulations that drive fibrosis and inflammation in the mouse AH model and human alcohol-as-sociated cirrhosis (120, 121).”
The gut-liver axis and the intersection with the microbiome
Tripathi, A., Debelius, J., Brenner, D. A., Karin, M., Loomba, R., Schnabl, B., & Knight, R. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0011-z · Cited by 1,480 · cited 1×
“Moreover, alcohol misuse and ALD are associated with small intestinal bacterial overgrowth, alterations of gut microbiota (“dysbiosis”), and bacterial translocation (46, 47).”
BackgroundPathophysiology of Inflammatory Bowel Diseases
Chang, J. T. (2020) · New England Journal of Medicine · doi:10.1056/nejmra2002697 · Cited by 1,295
Seitz, H. K., Bataller, R., Cortez-Pinto, H., Gao, B., Gual, A., Lackner, C., Mathurin, P., Mueller, S., Szabo, G., & Tsukamoto, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0014-7 · Cited by 1,271
Self-citationMouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213
Self-citationSpeliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984 · cited 1×
“MBOAT7 rs641738 and NCAN rs2228603, two common variants related to the development and severity of MASLD as well as liver fat content (164, 165), are found to increase the risk for cirrhosis and HCC development in ALD (93, 166).”
Crabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L., & Lucey, M. R. (2020) · Hepatology · doi:10.1002/hep.30866 · Cited by 922
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
Tapper, E. B., & Parikh, N. D. (2018) · BMJ · doi:10.1136/bmj.k2817 · Cited by 856
Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease
Duan, Y., Llorente, C., Lang, S., Brandl, K., Chu, H., Jiang, L., White, R. C., Clarke, T. H., Nguyen, K., Torralba, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1742-x · Cited by 844
Self-citationA Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
Abul-Husn, N. S., Cheng, X., Li, A. H., Xin, Y., Schurmann, C., Stevis, P., Liu, Y., Kozlitina, J., Stender, S., Wood, G. C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712191 · Cited by 827
Akriviadis, E., Botla, R., Briggs, W., Han, S., Reynolds, T., & Shakil, O. (2000) · Gastroenterology · doi:10.1053/gast.2000.20189 · Cited by 800
Enteric dysbiosis associated with a mouse model of alcoholic liver disease
Yan, A. W., Fouts, D. E., Brandl, J., Stärkel, P., Torralba, M., Schott, E., Tsukamoto, H., Nelson, K. E., Brenner, D. A., & Schnabl, B. (2011) · Hepatology · doi:10.1002/hep.24018 · Cited by 791
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020) · Hepatology · doi:10.1002/hep.31173 · Cited by 788
Mancina, R. M., Dongiovanni, P., Petta, S., Pingitore, P., Meroni, M., Rametta, R., Borén, J., Montalcini, T., Pujia, A., Wiklund, O., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.032 · Cited by 676
Alcohol as a risk factor for liver cirrhosis: A systematic review and meta‐analysis
REHM, J., TAYLOR, B., MOHAPATRA, S., IRVING, H., BALIUNAS, D., PATRA, J., & ROERECKE, M. (2010) · Drug and Alcohol Review · doi:10.1111/j.1465-3362.2009.00153.x · Cited by 668
Bajaj, J. S., Kassam, Z., Fagan, A., Gavis, E. A., Liu, E., Cox, I. J., Kheradman, R., Heuman, D., Wang, J., Gurry, T., et al. (2017) · Hepatology · doi:10.1002/hep.29306 · Cited by 633
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Self-citationBuch, S., Stickel, F., Trépo, E., Way, M., Herrmann, A., Nischalke, H. D., Brosch, M., Rosendahl, J., Berg, T., Ridinger, M., et al. (2015) · Nature Genetics · doi:10.1038/ng.3417 · Cited by 565 · cited 3×
“MBOAT7 rs641738 and NCAN rs2228603, two common variants related to the development and severity of MASLD as well as liver fat content (164, 165), are found to increase the risk for cirrhosis and HCC development in ALD (93, 166).”
Krenkel, O., Puengel, T., Govaere, O., Abdallah, A. T., Mossanen, J. C., Kohlhepp, M., Liepelt, A., Lefebvre, E., Luedde, T., Hellerbrand, C., et al. (2018) · Hepatology · doi:10.1002/hep.29544 · Cited by 557
Crabb, D. W., Bataller, R., Chalasani, N. P., Kamath, P. S., Lucey, M., Mathurin, P., McClain, C., McCullough, A., Mitchell, M. C., Morgan, T. R., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.042 · Cited by 553
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553
Huang, D. Q., Singal, A. G., Kono, Y., Tan, D. J. H., El-Serag, H. B., & Loomba, R. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.05.003 · Cited by 534
MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases
Wang, X., He, Y., Mackowiak, B., & Gao, B. (2021) · Gut · doi:10.1136/gutjnl-2020-322526 · Cited by 495
Self-citationVariant in PNPLA3 is associated with alcoholic liver disease
Tian, C., Stokowski, R. P., Kershenobich, D., Ballinger, D. G., & Hinds, D. A. (2010) · Nature Genetics · doi:10.1038/ng.488 · Cited by 438
Ki, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B. (2010) · Hepatology · doi:10.1002/hep.23837 · Cited by 434
Self-citationDuctular reaction in liver diseases: pathological mechanisms and translational significances
Sato, K., Marzioni, M., Meng, F., Francis, H., Glaser, S., & Alpini, G. (2019) · Hepatology · doi:10.1002/hep.30150 · Cited by 423 · cited 2×
“Ductular reaction (DR) is associated with advanced ALD and is characterized by an increased number of cholangiocytes along with inflammatory cell infiltration and loss of hepatocytes (66).”
Glucocorticoids plus N-Acetylcysteine in Severe Alcoholic Hepatitis
Nguyen-Khac, E., Thevenot, T., Piquet, M.-A., Benferhat, S., Goria, O., Chatelain, D., Tramier, B., Dewaele, F., Ghrib, S., Rudler, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101214 · Cited by 410
Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review
Singal, A. K., & Mathurin, P. (2021) · JAMA · doi:10.1001/jama.2021.7683 · Cited by 398 · cited 1×
“The risk of alcohol-related cirrhosis in male and female heavy drinkers (at age 40 years, with 10 drinks/day for more than 15 years) is 3.1% and 4.7%, respectively (183, 184).”
BackgroundInfluentialInflammatory pathways in alcoholic steatohepatitis
Gao, B., Ahmad, M. F., Nagy, L. E., & Tsukamoto, H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.023 · Cited by 392
Self-citationDiagnosis and Management of Cirrhosis and Its Complications: A Review
Tapper, E. B., & Parikh, N. D. (2023) · JAMA · doi:10.1001/jama.2023.5997 · Cited by 392
A Recent Perspective on Alcohol, Immunity, and Host Defense
Szabo, G., & Mandrekar, P. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00842.x · Cited by 387 · cited 1×
“Paradoxically, alcohol is a well-known immunoregulator that strongly inhibits the immune system, causing the increased host susceptibility to bacterial and viral infections (26).”
The Healthy Microbiome—What Is the Definition of a Healthy Gut Microbiome?
Shanahan, F., Ghosh, T. S., & O’Toole, P. W. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.09.057 · Cited by 383
Autophagy in liver diseases: A review
Qian, H., Chao, X., Williams, J., Fulte, S., Li, T., Yang, L., & Ding, W.-X. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100973 · Cited by 373
Mutlu, E., Keshavarzian, A., Engen, P., Forsyth, C. B., Sikaroodi, M., & Gillevet, P. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01022.x · Cited by 370
Hendrikx, T., Duan, Y., Wang, Y., Oh, J.-H., Alexander, L. M., Huang, W., Stärkel, P., Ho, S. B., Gao, B., Fiehn, O., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317232 · Cited by 361
Self-citationBoetticher, N. C., Peine, C. J., Kwo, P., Abrams, G. A., Patel, T., Aqel, B., Boardman, L., Gores, G. J., Harmsen, W. S., McClain, C. J., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.08.057 · Cited by 340
Noninvasive proteomic biomarkers for alcohol-related liver disease
Niu, L., Thiele, M., Geyer, P. E., Rasmussen, D. N., Webel, H. E., Santos, A., Gupta, R., Meier, F., Strauss, M., Kjaergaard, M., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01850-y · Cited by 309
Experimental methods of ethanol administration
Lieber, C. S., Decarli, L. M., & Sorrell, M. F. (1989) · Hepatology · doi:10.1002/hep.1840100417 · Cited by 290
Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease
Wu, X., Fan, X., Miyata, T., Kim, A., Cajigas-Du Ross, C. K., Ray, S., Huang, E., Taiwo, M., Arya, R., Wu, J., et al. (2023) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-031521-030435 · Cited by 289
Bertola, A., Park, O., & Gao, B. (2013) · Hepatology · doi:10.1002/hep.26419 · Cited by 282
Self-citationRole and Mechanisms of Mitophagy in Liver Diseases
Ma, X., McKeen, T., Zhang, J., & Ding, W.-X. (2020) · Cells · doi:10.3390/cells9040837 · Cited by 279
Bataller, R., Arab, J. P., & Shah, V. H. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2207599 · Cited by 259 · cited 4×
“The pathogenesis and clinical management of ALD have been recently summarized in numerous reviews (4–6, 12, 15–18).”
BackgroundInfluentialResearch advances in ethanol metabolism
Ramchandani, V. A., Bosron, W. F., & Li, T. K. (2001) · Pathologie Biologie · doi:10.1016/s0369-8114(01)00232-2 · Cited by 241
Louvet, A., Thursz, M. R., Kim, D. J., Labreuche, J., Atkinson, S. R., Sidhu, S. S., O’Grady, J. G., Akriviadis, E., Sinakos, E., Carithers, R. L., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.011 · Cited by 236
Li, M., He, Y., Zhou, Z., Ramirez, T., Gao, Y., Gao, Y., Ross, R. A., Cao, H., Cai, Y., Xu, M., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-311861 · Cited by 229
Self-citationPyroptosis by caspase11/4‐gasdermin‐D pathway in alcoholic hepatitis in mice and patients
Khanova, E., Wu, R., Wang, W., Yan, R., Chen, Y., French, S. W., Llorente, C., Pan, S. Q., Yang, Q., Li, Y., et al. (2018) · Hepatology · doi:10.1002/hep.29645 · Cited by 228 · cited 1×
“Several other mouse transcriptomic studies have enhanced our understanding of ALD, including the role of gasdermin D–mediated pyroptosis and neutrophil cytosolic factor 1–mediated oxidative stress, among others (30, 103–107).”
BackgroundALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective
Chang, J. S., Hsiao, J.-R., & Chen, C.-H. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0327-y · Cited by 223
Spahr, L., Lambert, J., Rubbia‐Brandt, L., Chalandon, Y., Frossard, J., Giostra, E., & Hadengue, A. (2008) · Hepatology · doi:10.1002/hep.22317 · Cited by 221
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
Rogal, S., Youk, A., Zhang, H., Gellad, W. F., Fine, M. J., Good, C. B., Chartier, M., DiMartini, A., Morgan, T., Bataller, R., et al. (2020) · Hepatology · doi:10.1002/hep.31042 · Cited by 218
Ambade, A., Lowe, P., Kodys, K., Catalano, D., Gyongyosi, B., Cho, Y., Iracheta‐Vellve, A., Adejumo, A., Saha, B., Calenda, C., et al. (2019) · Hepatology · doi:10.1002/hep.30249 · Cited by 214
Chang, B., Xu, M., Zhou, Z., Cai, Y., Li, M., Wang, W., Feng, D., Bertola, A., Wang, H., Kunos, G., et al. (2015) · Hepatology · doi:10.1002/hep.27921 · Cited by 210
Self-citationAffò, S., Dominguez, M., Lozano, J. J., Sancho-Bru, P., Rodrigo-Torres, D., Morales-Ibanez, O., Moreno, M., Millán, C., Loaeza-del-Castillo, A., Altamirano, J., et al. (2013) · Gut · doi:10.1136/gutjnl-2011-301146 · Cited by 207
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207 · cited 1×
“The combination of metabolic dysfunction and heavy alcohol consumption in this unique patient population exhibits overlapping and distinct mechanisms of liver disease progression which have been recently reviewed (145).”
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting
Avila, M. A., Dufour, J.-F., Gerbes, A. L., Zoulim, F., Bataller, R., Burra, P., Cortez-Pinto, H., Gao, B., Gilmore, I., Mathurin, P., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319720 · Cited by 206
Self-citationArgemi, J., Latasa, M. U., Atkinson, S. R., Blokhin, I. O., Massey, V., Gue, J. P., Cabezas, J., Lozano, J. J., Van Booven, D., Bell, A., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11004-3 · Cited by 203
Wrzosek, L., Ciocan, D., Hugot, C., Spatz, M., Dupeux, M., Houron, C., Lievin-Le Moal, V., Puchois, V., Ferrere, G., Trainel, N., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321565 · Cited by 202
Arab, J. P., Sehrawat, T. S., Simonetto, D. A., Verma, V. K., Feng, D., Tang, T., Dreyer, K., Yan, X., Daley, W. L., Sanyal, A., et al. (2020) · Hepatology · doi:10.1002/hep.31046 · Cited by 201
Self-citationA randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis
Stewart, S., Prince, M., Bassendine, M., Hudson, M., James, O., Jones, D., Record, C., & Day, C. P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.027 · Cited by 196
Kwon, H.-J., Won, Y.-S., Park, O., Chang, B., Duryee, M. J., Thiele, G. E., Matsumoto, A., Singh, S., Abdelmegeed, M. A., Song, B.-J., et al. (2014) · Hepatology · doi:10.1002/hep.27036 · Cited by 191
Self-citationXiang, X., Feng, D., Hwang, S., Ren, T., Wang, X., Trojnar, E., Matyas, C., Mo, R., Shang, D., He, Y., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.013 · Cited by 189
Self-citationInterleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple Targets
Hwang, S., He, Y., Xiang, X., Seo, W., Kim, S., Ma, J., Ren, T., Park, S. H., Zhou, Z., Feng, D., et al. (2020) · Hepatology · doi:10.1002/hep.31031 · Cited by 177
Self-citationJulien, J., Ayer, T., Bethea, E. D., Tapper, E. B., & Chhatwal, J. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30062-1 · Cited by 176
Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease
Parks, O. B., Pociask, D. A., Hodzic, Z., Kolls, J. K., & Good, M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00085 · Cited by 175
Mata, A. M., González-Diéguez, M.-L., Cadahía, V., Varela, M., Pérez, R., Navascués, C. Á., Sotorríos, N. G., Martínez, M., Rodrigo, L., & Rodríguez, M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.09.007 · Cited by 174
Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations
Parker, R., Kim, S.-J., & Gao, B. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.116 · Cited by 174
Self-citationThe genetics of alcohol dependence and alcohol-related liver disease
Stickel, F., Moreno, C., Hampe, J., & Morgan, M. Y. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.011 · Cited by 165
Neutrophil-Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis
Zhou, Z., Xu, M.-J., Cai, Y., Wang, W., Jiang, J. X., Varga, Z. V., Feng, D., Pacher, P., Kunos, G., Torok, N. J., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.01.003 · Cited by 164
Self-citationEngelmann, C., Herber, A., Franke, A., Bruns, T., Reuken, P. A., Schiefke, I., Zipprich, A., Zeuzem, S., Goeser, T., Canbay, A. E., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.07.033 · Cited by 162
Hao, L., Zhong, W., Dong, H., Guo, W., Sun, X., Zhang, W., Yue, R., Li, T., Griffiths, A., Ahmadi, A. R., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321548 · Cited by 161
Trépo, E., Gustot, T., Degré, D., Lemmers, A., Verset, L., Demetter, P., Ouziel, R., Quertinmont, E., Vercruysse, V., Amininejad, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.028 · Cited by 160
Aldehyde Dehydrogenase, Liver Disease and Cancer
Wang, W., Wang, C., Xu, H., & Gao, Y. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.42300 · Cited by 150
Reducing the Global Burden of Alcohol‐Associated Liver Disease: A Blueprint for Action
Asrani, S. K., Mellinger, J., Arab, J. P., & Shah, V. H. (2021) · Hepatology · doi:10.1002/hep.31583 · Cited by 150
Fat-Specific Protein 27/CIDEC Promotes Development of Alcoholic Steatohepatitis in Mice and Humans
Xu, M.-J., Cai, Y., Wang, H., Altamirano, J., Chang, B., Bertola, A., Odena, G., Lu, J., Tanaka, N., Matsusue, K., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.009 · Cited by 145
Self-citationIntestinal Virome in Patients With Alcoholic Hepatitis
Jiang, L., Lang, S., Duan, Y., Zhang, X., Gao, B., Chopyk, J., Schwanemann, L. K., Ventura‐Cots, M., Bataller, R., Bosques‐Padilla, F., et al. (2020) · Hepatology · doi:10.1002/hep.31459 · Cited by 145
Self-citationRodent models of alcoholic liver disease: Of mice and men
Brandon-Warner, E., Schrum, L. W., Schmidt, C. M., & McKillop, I. H. (2012) · Alcohol · doi:10.1016/j.alcohol.2012.08.004 · Cited by 143
Cho, Y., Bukong, T. N., Tornai, D., Babuta, M., Vlachos, I. S., Kanata, E., Catalano, D., & Szabo, G. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.029 · Cited by 143 · cited 2×
“The detrimental effects of macrophages in ALD are likely due to production of a variety of inflammatory mediators (17), while neutrophils exacerbate ALD by producing ROS, inflammatory mediators, and neutrophil extracellular traps (27, 28).”
Vannier, A. G. L., Shay, J. E. S., Fomin, V., Patel, S. J., Schaefer, E., Goodman, R. P., & Luther, J. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.13014 · Cited by 137
Role of mitochondria in alcoholic liver disease
Nassir, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i9.2136 · Cited by 135
Louvet, A., Labreuche, J., Moreno, C., Vanlemmens, C., Moirand, R., Féray, C., Dumortier, J., Pageaux, G.-P., Bureau, C., Chermak, F., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00430-1 · Cited by 134
Homann, N., Stickel, F., König, I. R., Jacobs, A., Junghanns, K., Benesova, M., Schuppan, D., Himsel, S., Zuber‐Jerger, I., Hellerbrand, C., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21583 · Cited by 132
Ma, X., Chen, A., Melo, L., Clemente‐Sanchez, A., Chao, X., Ahmadi, A. R., Peiffer, B., Sun, Z., Sesaki, H., Li, T., et al. (2023) · Hepatology · doi:10.1002/hep.32604 · Cited by 127
Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice
Lazaro, R., Wu, R., Lee, S., Zhu, N., Chen, C., French, S. W., Xu, J., Machida, K., & Tsukamoto, H. (2015) · Hepatology · doi:10.1002/hep.27383 · Cited by 120
Super enhancer regulation of cytokine-induced chemokine production in alcoholic hepatitis
Liu, M., Cao, S., He, L., Gao, J., Arab, J. P., Cui, H., Xuan, W., Gao, Y., Sehrawat, T. S., Hamdan, F. H., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24843-w · Cited by 120
Carbone, M., Nardi, A., Flack, S., Carpino, G., Varvaropoulou, N., Gavrila, C., Spicer, A., Badrock, J., Bernuzzi, F., Cardinale, V., et al. (2018) · HAL (Le Centre pour la Communication Scientifique Directe) · doi:10.1016/s2468-1253 · Cited by 120
Kuper, H., Ye, W., Broomé, U., ROMELSJÖ, A., Mucci, L. A., Ekbom, A., Adami, H., Trichopoulos, D., & Nyrén, O. (2001) · Hepatology · doi:10.1053/jhep.2001.28233 · Cited by 119
Stickel, F., Buch, S., Nischalke, H. D., Weiss, K. H., Gotthardt, D., Fischer, J., Rosendahl, J., Marot, A., Elamly, M., Casper, M., et al. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0041-8 · Cited by 118
Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance
Gao, B., Xu, M.-J., Bertola, A., Wang, H., Zhou, Z., & Liangpunsakul, S. (2017) · Gene Expression · doi:10.3727/105221617x695519 · Cited by 116
Self-citationGuillot, A., Winkler, M., Silva Afonso, M., Aggarwal, A., Lopez, D., Berger, H., Kohlhepp, M. S., Liu, H., Özdirik, B., Eschrich, J., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000270 · Cited by 116
Self-citationEguchi, A., Lazaro, R. G., Wang, J., Kim, J., Povero, D., Willliams, B., Ho, S. B., Stärkel, P., Schnabl, B., Ohno‐Machado, L., et al. (2017) · Hepatology · doi:10.1002/hep.28838 · Cited by 115
Giant Mitochondria in Hepatocytes
Bruguera, M., Bertran, A., Bombí, J. A., & Rodés, J. (1977) · Gastroenterology · doi:10.1016/s0016-5085(19)31518-5 · Cited by 114
Trépo, E., Caruso, S., Yang, J., Imbeaud, S., Couchy, G., Bayard, Q., Letouzé, É., Ganne‐Carrié, N., Moreno, C., Oussalah, A., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00603-3 · Cited by 112
Pande, A., Sharma, S., Khillan, V., Rastogi, A., Arora, V., Shasthry, S. M., Vijayaraghavan, R., Jagdish, R. K., Kumar, M., Kumar, G., et al. (2022) · Hepatology International · doi:10.1007/s12072-022-10438-0 · Cited by 108
Mouse intragastric infusion (iG) model
Ueno, A., Lazaro, R., Wang, P.-Y., Higashiyama, R., Machida, K., & Tsukamoto, H. (2012) · Nature Protocols · doi:10.1038/nprot.2012.014 · Cited by 105
Genetic and Epigenetic Modifiers of Alcoholic Liver Disease
Meroni, M., Longo, M., Rametta, R., & Dongiovanni, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123857 · Cited by 105
IL‐1 receptor antagonist plus pentoxifylline and zinc for severe alcohol‐associated hepatitis
Szabo, G., Mitchell, M., McClain, C. J., Dasarathy, S., Barton, B., McCullough, A. J., Nagy, L. E., Kroll‐Desrosiers, A., Tornai, D., Min, H. A., et al. (2022) · Hepatology · doi:10.1002/hep.32478 · Cited by 105
Kirpich, I., Petrosino, J. F., Ajami, N. J., Feng, W., Wang, Y., Liu, Y., Beier, J. I., Barve, S. S., Yin, X., Wei, X., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.11.017 · Cited by 100
Microbiota, a key player in alcoholic liver disease
Cassard, A.-M., & Ciocan, D. (2018) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0067 · Cited by 100
Schwantes‐An, T., Darlay, R., Mathurin, P., Masson, S., Liangpunsakul, S., Mueller, S., Aithal, G. P., Eyer, F., Gleeson, D., Thompson, A., et al. (2021) · Hepatology · doi:10.1002/hep.31535 · Cited by 99
“Second Hit” Models of Alcoholic Liver Disease
Tsukamoto, H., Machida, K., Dynnyk, A., & Mkrtchyan, H. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1214373 · Cited by 93
Feng, D., Xiang, X., Guan, Y., Guillot, A., Lu, H., Chang, C., He, Y., Wang, H., Pan, H., Ju, C., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci166954 · Cited by 93 · cited 1×
“However, recent studies have identified many subsets of macrophages, with some of them playing an important role in promoting liver repair and fibrosis resolution (38, 39), thus, selective inhibition of inflammatory macrophage infiltration may achieve better clinical outcomes for ALD treatment.”
BackgroundSelf-citationMa, J., Guillot, A., Yang, Z., Mackowiak, B., Hwang, S., Park, O., Peiffer, B. J., Ahmadi, A. R., Melo, L., Kusumanchi, P., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157780 · Cited by 90 · cited 3×
“This technique has been widely applied to investigate the tumor microenvironment and other types of liver disease but has only recently been utilized to interrogate the pathology of ALD (30, 31, 71).”
BackgroundMethodSelf-citationMetALD: new opportunities to understand the role of alcohol in steatotic liver disease
Israelsen, M. E., Torp, N., Johansen, S., Thiele, M. S., & Krag, A. A. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00206-6 · Cited by 90
Chen, Y.-C., Peng, G.-S., Tsao, T., Wang, M.-F., Lu, R., & Yin, S. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832ecf2e · Cited by 89
ADH1B: From alcoholism, natural selection, and cancer to the human phenome
Polimanti, R., & Gelernter, J. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32523 · Cited by 89
Aguilar‐Bravo, B., Rodrigo‐Torres, D., Ariño, S., Coll, M., Pose, E., Blaya, D., Graupera, I., Perea, L., Vallverdú, J., Rubio‐Tomás, T., et al. (2019) · Hepatology · doi:10.1002/hep.30472 · Cited by 89
Sakamoto, T., Hara, M., Higaki, Y., Ichiba, M., Horita, M., Mizuta, T., Eguchi, Y., Yasutake, T., Ozaki, I., Yamamoto, K., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21505 · Cited by 88 · cited 13×
“Among patients with ALD, the annual incidence of A-HCC is 5.6 cases per 1,000 person-years (152).”
BackgroundInfluentialBrandon‐Warner, E., Walling, T. L., Schrum, L. W., & McKillop, I. H. (2012) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01660.x · Cited by 88
Guillot, A., Guerri, L., Feng, D., Kim, S.-J., Ahmed, Y. A., Paloczi, J., He, Y., Schuebel, K., Dai, S., Liu, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci132305 · Cited by 86 · cited 1×
“Indeed, a study from an experimental model revealed that macrophages promote ductular cell repair and proliferation after acute bile duct injury (128).”
BackgroundSelf-citationBou Saleh, M., Louvet, A., Ntandja-Wandji, L. C., Boleslawski, E., Gnemmi, V., Lassailly, G., Truant, S., Maggiotto, F., Ningarhari, M., Artru, F., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.05.041 · Cited by 83 · cited 1×
“In addition, a previous study using microdissection to determine gene expression in different spatial areas found that increased yes-associated protein (YAP) signaling in hepatocytes leads to biliary transdifferentiation as a mechanism of AH (122).”
BackgroundBucci, L., Garuti, F., Camelli, V., Lenzi, B., Farinati, F., Giannini, E. G., Ciccarese, F., Piscaglia, F., Rapaccini, G. L., Di Marco, M., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13485 · Cited by 82
Bloom, P. P., Donlan, J., Soto, M. T., Daidone, M., Hohmann, E. L., & Chung, R. T. (2022) · Hepatology Communications · doi:10.1002/hep4.1950 · Cited by 82
Costentin, C. E., Mourad, A., Lahmek, P., Causse, X., Pariente, A., Hagège, H., Dobrin, A. S., Becker, C., Marks, B., Bader, R., et al. (2018) · Cancer · doi:10.1002/cncr.31215 · Cited by 81
Binge Ethanol and Liver: New Molecular Developments
Shukla, S. D., Pruett, S. B., Szabo, G., & Arteel, G. E. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12011 · Cited by 79
Innes, H., Buch, S., Hutchinson, S., Guha, I. N., Morling, J. R., Barnes, E., Irving, W., Forrest, E., Pedergnana, V., Goldberg, D., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.014 · Cited by 79
Park, S. H., Seo, W., Xu, M.-J., Mackowiak, B., Lin, Y., He, Y., Fu, Y., Hwang, S., Kim, S.-J., Guan, Y., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.10.002 · Cited by 77
Self-citationHyun, J., Sun, Z., Ahmadi, A. R., Bangru, S., Chembazhi, U. V., Du, K., Chen, T., Tsukamoto, H., Rusyn, I., Kalsotra, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci132691 · Cited by 76 · cited 1×
“For example, Hyun et al. recently found that epithelial splicing regulatory protein 2 plays an important role in controlling hepatocyte reprogramming in AH (125).”
BackgroundQian, M., Liu, J., Zhao, D., Cai, P., Pan, C., Jia, W., Gao, Y., Zhang, Y., Zhang, N., Zhang, Y., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.014 · Cited by 76
Zhong, W., Wei, X., Hao, L., Lin, T., Yue, R., Sun, X., Guo, W., Dong, H., Li, T., Ahmadi, A. R., et al. (2020) · Hepatology · doi:10.1002/hep.30945 · Cited by 73
Massey, V. L., Parrish, A., Argemí, J., Moreno, M., Mello, A., Garcı́a-Rocha, M., Altamirano, J., Òdena, G., Dubuquoy, L., Louvet, A., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.12.008 · Cited by 73
Chao, X., Wang, S., Fulte, S., Ma, X., Ahamed, F., Cui, W., Liu, Z., Rülicke, T., Zatloukal, K., Zong, W., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.10.014 · Cited by 72
Kim, H.-S., Xiao, X., Byun, J., Jun, G., DeSantis, S. M., Chen, H., Thrift, A. P., El-Serag, H. B., Kanwal, F., & Amos, C. I. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.34221 · Cited by 69
Alcohol-associated bowel disease: new insights into pathogenesis
Maccioni, L., Fu, Y., Horsmans, Y., Leclercq, I., Stärkel, P., Kunos, G., & Gao, B. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100013 · Cited by 69
Self-citationTargeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking
Guillot, A., Ren, T., Jourdan, T., Pawlosky, R. J., Han, E., Kim, S.-J., Zhang, L., Koob, G. F., & Gao, B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1908137116 · Cited by 68
Self-citationRole of autophagy in alcohol and drug-induced liver injury
Williams, J. A. R., & Ding, W. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.111075 · Cited by 67
Vatsalya, V., Feng, W., Kong, M., Hu, H., Szabo, G., McCullough, A., Dasarathy, S., Nagy, L. E., Radaeva, S., Barton, B., et al. (2023) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002283 · Cited by 64
la Tijera, F. H., Servín-Caamaño, A., Cruz-Herrera, J. E., Serralde-Zúñiga, A. E., Abdo-Francis, J. M., Gutiérrez‐Reyes, G., & Pérez-Hernández, J. L. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30863-4 · Cited by 63
Serum Metabolomic Profiling in Acute Alcoholic Hepatitis Identifies Multiple Dysregulated Pathways
Rachakonda, V. P., Gabbert, C. C., Raina, A., Bell, L. N., Cooper, S. J., Malik, S. M., & Behari, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113860 · Cited by 62
Trépo, E., Goossens, N., Fujiwara, N., Song, W., Colaprico, A., Marot, A., Spahr, L., Demetter, P., Sempoux, C. L., Im, G. Y., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.10.048 · Cited by 61
Gao, Y., Zhou, Z., Ren, T., Kim, S.-J., He, Y., Seo, W., Guillot, A., Ding, Y., Wu, R., Shao, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316221 · Cited by 61
Self-citationLong non-coding RNA ACTA2-AS1 promotes ductular reaction by interacting with the p300/ELK1 complex
Navarro‐Corcuera, A., Sehrawat, T. S., Jalan‐Sakrikar, N., Gibbons, H. R., Pirius, N., Khanal, S., Hamdan, F. H., Aseem, S. O., Cao, S., Bañales, J. M., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.014 · Cited by 59
Ariño, S., Aguilar-Bravo, B., Coll, M., Lee, W.-Y., Peiseler, M., Cantallops-Vilà, P., Sererols-Viñas, L., Martínez-García de la Torre, R. A., Martínez-Sánchez, C., Pedragosa, J., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.045 · Cited by 59
Wieser, V., Adolph, T. E., Enrich, B., Kuliopulos, A., Kaser, A., Tilg, H., & Kaneider, N. C. (2017) · Gut · doi:10.1136/gutjnl-2015-310344 · Cited by 58
The role of neutrophils in alcohol-related hepatitis
Khan, R. S., Lalor, P. F., Thursz, M., & Newsome, P. N. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.05.017 · Cited by 57
Buch, S., Innes, H. A., Lutz, P. L., Nischalke, H. D., Marquardt, J. U., Fischer, J., Weiss, K. H., Rosendahl, J., Marot, A., Krawczyk, M. J., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327196 · Cited by 56
Fungal infections and the fungal microbiome in hepatobiliary disorders
Hartmann, P., & Schnabl, B. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.12.006 · Cited by 56
Yang, Z., Ross, R. A., Zhao, S., Tu, W., Liangpunsakul, S., & Wang, L. (2017) · Hepatology Communications · doi:10.1002/hep4.1061 · Cited by 55
Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion
Deaciuc, I. V., Doherty, D. E., Burikhanov, R., Lee, E. Y., Stromberg, A. J., Peng, X., & de Villiers, W. J. S. (2003) · Journal of Hepatology · doi:10.1016/j.jhep.2003.10.021 · Cited by 54
Intragastric Ethanol Infusion Model in Rodents
Tsukamoto, H., Mkrtchyan, H., & Dynnyk, A. (2008) · Methods in Molecular Biology™ · doi:10.1007/978-1-59745-242-7_3 · Cited by 54
Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice
Zhang, Z., Zhong, X., Shen, H., Sheng, L., Liangpunsakul, S., Lok, A. S., Omary, M. B., Wang, S., & Rui, L. (2022) · Nature Communications · doi:10.1038/s41467-022-32575-8 · Cited by 53
Women and alcoholic liver disease — warning of a silent danger
Szabó, G. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2018.8 · Cited by 51
Macrophage‐derived MLKL in alcohol‐associated liver disease: Regulation of phagocytosis
Wu, X., Fan, X., McMullen, M. R., Miyata, T., Kim, A., Pathak, V., Wu, J., Day, L. Z., Hardesty, J., Welch, N., et al. (2022) · Hepatology · doi:10.1002/hep.32612 · Cited by 49
Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis
Weichselbaum, L., Azouz, A., Smolen, K. K., Das, J., Splittgerber, M., Lepida, A., Moreno, C., Schreiber, J., Sersté, T., Trépo, E., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.02.017 · Cited by 47
Schonfeld, M. P., O’Neil, M. F., Villar, M. T., Artigues, A., Averilla, J. N., Gunewardena, S., Weinman, S. A., & Tikhanovich, I. (2021) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14700 · Cited by 47
Nischalke, H. D., Lutz, P., Krämer, B., Söhne, J., Müller, T., Rosendahl, J., Fischer, J., Berg, T., Hittatiya, K., Fischer, H.-P., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.006 · Cited by 46
Role and mechanisms of autophagy in alcohol-induced liver injury
Chao, X., & Ding, W. (2019) · Advances in pharmacology · doi:10.1016/bs.apha.2019.01.008 · Cited by 46
Guillot, A., Kohlhepp, M., Bruneau, A., Heymann, F., & Tacke, F. (2020) · Cancers · doi:10.3390/cancers12092449 · Cited by 46
Mathur, M., Yeh, Y., Arya, R. K., Jiang, L., Pornour, M., Chen, W., Ma, Y., Gao, B., He, L., Ying, Z., et al. (2023) · Hepatology · doi:10.1002/hep.32675 · Cited by 45
Self-citationKann, A. E., Jepsen, P., Madsen, L. G., West, J., & Askgaard, G. (2023) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00192-9 · Cited by 43
Hagström, H., Thiele, M., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J., & Ludvigsson, J. F. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.005 · Cited by 42
Kouno, T., Zeng, S.-L., Wang, Y., Duan, Y., Lang, S., Gao, B., Hartmann, P., Cabré, N., Llorente, C., Galbert, C., et al. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15048 · Cited by 41
Self-citationHassanein, T., McClain, C. J., Vatsalya, V., Stein, L. L., Flamm, S. L., Martin, P. B., Cave, M. C., Mitchell, M. C., BARTON, B. A., Nagy, L. E., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002275 · Cited by 41
Spatial dimension of macrophage heterogeneity in liver diseases
Guillot, A., & Tacke, F. (2023) · eGastroenterology · doi:10.1136/egastro-2023-000003 · Cited by 40
Elßner, C., Goeppert, B., Longerich, T., Scherr, A.-L., Stindt, J., Nanduri, L. K., Rupp, C., Kather, J. N., Schmitt, N., Kautz, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.018 · Cited by 39
The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease
Yang, Z., Smalling, R. V., Huang, Y., Jiang, Y., Kusumanchi, P., Bogaert, W., Wang, L., Delker, D. A., Skill, N. J., Han, S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.140687 · Cited by 37
The Changing Epidemiology of Alcohol-Associated Liver Disease: Gender, Race, and Risk Factors
Anouti, A., & Mellinger, J. L. (2023) · Seminars in Liver Disease · doi:10.1055/a-2000-6680 · Cited by 37
Aguilar‐Bravo, B., Ariño, S., Blaya, D., Pose, E., de la Torre, R. A. M. G., Latasa, M. U., Martínez–Sánchez, C., Zanatto, L., Sererols-Viñas, L., Vilà, P. C., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.013 · Cited by 37
Abe, H., Aida, Y., Seki, N., Sugita, T., Tomita, Y., Nagano, T., Itagaki, M., Sutoh, S., Nagatsuma, K., Itoh, K., et al. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12948 · Cited by 35
Liu, X., Rosenthal, S. B., Meshgin, N., Baglieri, J., Musallam, S. G., Diggle, K., Lam, K., Wu, R. P., Pan, S. Q., Chen, Y., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1483 · Cited by 34
Li, G., Chen, H.-Q., Shen, F., Smithson, S. B., Shealy, G. L., Ping, Q., Liang, Z., Han, J., Adams, A. C., Li, Y., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000433 · Cited by 32
Self-citationIlyas, F., Ali, H., Patel, P., Sarfraz, S., Basuli, D., Giammarino, A. M., & Satapathy, S. K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000207 · Cited by 32
Tayek, J. A., Stolz, A., Nguyen, D. V., Fleischman, M. W., Donovan, J. A., Alcorn, J. M., Chao, D., Asghar, A., Morgan, T. R. M., Birudaraju, D., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101689 · Cited by 31
Chao, X., Wang, S., Ma, X., Zhang, C., Qian, H., Williams, S. N., Sun, Z., Peng, Z., Liu, W., Li, F., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000373 · Cited by 30
Maintenance of Intestinal Epithelial Homeostasis by Zinc Transporters
Ohashi, W., Hara, T., Takagishi, T., Hase, K., & Fukada, T. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05561-2 · Cited by 29
Costentin, C. E., Sogni, P., Falissard, B., Barbare, J., Bendersky, N., Farges, O., & Goutté, N. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05724-1 · Cited by 29
Emerging targets for therapy in ALD: Lessons from NASH
Singal, A. K., Shah, V. H., & Malhi, H. (2023) · Hepatology · doi:10.1097/hep.0000000000000381 · Cited by 28
Mechanisms of liver fibrosis in metabolic syndrome
Mehal, W. (2023) · eGastroenterology · doi:10.1136/egastro-2023-100015 · Cited by 28
Clemente, A. P. G., Oliveira-Mello, A., & Bataller, R. A. (2021) · Clinics in Liver Disease · doi:10.1016/j.cld.2021.03.001 · Cited by 27
Hepatic Protein and Phosphoprotein Signatures of Alcohol-Associated Cirrhosis and Hepatitis
Hardesty, J., Day, L. Z., Warner, J. B., Warner, D. R., Gritsenko, M., Asghar, A., Stolz, A., Morgan, T. R. M., McClain, C. J., Jacobs, J., et al. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.04.004 · Cited by 26
Ilyas, F., Ali, H., Patel, P., Basuli, D., Giammarino, A. M., & Satapathy, S. K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000180 · Cited by 26
Experimental models of fatty liver diseases: Status and appraisal
Wang, H., Shen, H., Seo, W., & Hwang, S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000200 · Cited by 26
A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression
Delacôte, C., Bauvin, P., Louvet, A., Dautrecque, F., Wandji, L. C. N., Lassailly, G., Voican, C. S., Perlemuter, G., Naveau, S., Mathurin, P., et al. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.12.041 · Cited by 25
Innes, H. A., Nischalke, H. D., Guha, I. N., Weiss, K. H., Irving, W. L., Gotthardt, D. N., Barnes, E. J., Fischer, J., Ansari, M. A., Rosendahl, J., et al. (2021) · Hepatology Communications · doi:10.1002/hep4.1886 · Cited by 24
French, S. W., Mendoza, A. S., Afifiyan, N. F., Tillman, B. C., Vitocruz, E., & French, B. A. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.08.005 · Cited by 23
Listopad, S., Magnan, C., Asghar, A., Stolz, A., Tayek, J. A., Liu, Z., Morgan, T. R. M., & Norden‐Krichmar, T. M. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100560 · Cited by 22
Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism
Buyco, D. G., Dempsey, J. L., Scorletti, E., Jeon, S., Lin, C., Harkin, J., Bayen, S., Furth, E. E., Martin, J., Delima, M., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281954 · Cited by 22
Single-Cell RNA Transcriptome Profiling of Liver Cells of Short-Term Alcoholic Liver Injury in Mice
Cao, L., Wu, D., Qin, L., Tan, D., Fan, Q., Jia, X., Yang, M., Zhou, T., Feng, C., Lu, Y., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054344 · Cited by 21
Jiang, L., Chu, H., Gao, B., Lang, S., Wang, Y., Duan, Y., & Schnabl, B. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06461-6 · Cited by 20
Self-citationHarris, P. S., Michel, C. R., Yun, Y., McGinnis, C. D., Assiri, M. A., Ahmadi, A. R., Sun, Z., Roede, J. R., Burchill, M. A., Orlicky, D. J., et al. (2021) · Alcohol · doi:10.1016/j.alcohol.2021.11.005 · Cited by 19
The useful predictors of zinc deficiency for the management of chronic liver disease
Iritani, S., Kawamura, Y., Muraishi, N., Fujiyama, S., Sezaki, H., Hosaka, T., Akuta, N., Kobayashi, M., Saitoh, S., Suzuki, F., et al. (2022) · Journal of Gastroenterology · doi:10.1007/s00535-022-01852-0 · Cited by 19
Loss of SQSTM1/p62 Induces Obesity and Exacerbates Alcohol-Induced Liver Injury in Aged Mice
Qian, H., Chao, X., Wang, S., Li, Y., Jiang, X., Sun, Z., Rülicke, T., Zatloukal, K., Ni, H., & Ding, W. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.01.016 · Cited by 19
STING‐mediated inflammation contributes to Gao binge ethanol feeding model
Wang, L., You, H., Meng, H., Pan, X., Chen, X., Bi, Y., Zhang, Y., Li, J., Yin, N., Zhang, Z., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30606 · Cited by 18
Argemí, J., Kedia, K., Gritsenko, M. A., Clemente, A. P. G., Asghar, A., Herranz, J. M., Liu, Z., Atkinson, S. R., Smith, R. D., Norden‐Krichmar, T. M., et al. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.08.009 · Cited by 18
Ahmadi, A. R., Song, G., Gao, T., Ma, J., Han, X., Hu, M., Cameron, A. M., Wesson, R., Philosophe, B., Ottmann, S. E., et al. (2023) · eLife · doi:10.7554/elife.86678 · Cited by 18
Self-citationAn exploratory genome-wide analysis of genetic risk for alcoholic hepatitis
Beaudoin, J. J., Long, N., Liangpunsakul, S., Puri, P., Kamath, P. S., Shah, V. H., Sanyal, A. J., Crabb, D. W., Chalasani, N., Urban, T. J., et al. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1359664 · Cited by 16
Wu, M., Yin, F., Wei, X., Ren, R., Chen, C., Liu, M., Wang, R., Liu, Y., Xie, R.-Q., Jiang, S., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.67852 · Cited by 16
Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease
Ranjbarian, T., & Schnabl, B. (2023) · Seminars in Liver Disease · doi:10.1055/a-2145-7331 · Cited by 16
The circulating proteomic signature of alcohol-associated liver disease
Luther, J., Vannier, A., Schaefer, E. A. K., & Goodman, R. P. (2022) · JCI Insight · doi:10.1172/jci.insight.159775 · Cited by 15
Balog, S., Fujiwara, R., Pan, S. Q., Elbaradie, K., Choi, H. Y., Sinha, S., Yang, Q., Asahina, K., Chen, Y., Li, M., et al. (2022) · Hepatology · doi:10.1002/hep.32793 · Cited by 15
Alcohol‐Associated Liver Disease: East Versus West
Charatcharoenwitthaya, P., Liangpunsakul, S., & Piratvisuth, T. (2020) · Clinical Liver Disease · doi:10.1002/cld.920 · Cited by 13
Sex differences in clinical characteristics and outcomes associated with alcoholic hepatitis
Pemmasani, G., Tremaine, W. J., Kumar, V. C. S., Aswath, G., Sapkota, B. H., Karagozian, R., & John, S. (2023) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002612 · Cited by 13
Single ethanol binge causes severe liver injury in mice fed Western diet
Yeh, Y., Wu, X., Ma, Y., Ying, Z., He, L., Xue, B., Shi, H., Choi, Y., & Yu, L. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000174 · Cited by 12
Rapid in vivo multiplexed editing (RIME) of the adult mouse liver
Katsuda, T., Cure, H., Sussman, J., Simeonov, K. P., Krapp, C. J., Arany, Z. P., Grompe, M., & Stanger, B. Z. (2022) · Hepatology · doi:10.1002/hep.32759 · Cited by 10
Schmalz, F., Fischer, J., Innes, H. A., Buch, S., Möller, C., Matz‐Soja, M., Schönfels, W. V., Krämer, B., Langhans, B., Klüners, A., et al. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100684 · Cited by 8
Activation of cholangiocyte mTORC1 drives alcohol-induced ductular reaction
Mackowiak, B., & Gao, B. (2023) · Hepatology · doi:10.1097/hep.0000000000000416 · Cited by 2
Self-citation
Research works printed but not linked: 1
- 10.7554/eLife.86678.2 · DOI
Cited by
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
Seyhan, D., Allaire, M., Fu, Y., Conti, F., Wang, X. W., Gao, B., & Lafdil, F. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01308-4 · Cited by 164
Self-citationShen, H., Zhou, L., Zhang, H., Yang, Y., Jiang, L., Wu, D., Shu, H., Zhang, H., Xie, L., Zhou, K., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.06.008 · Cited by 132
(2025) · doi:10.1038/s41423-025-01313-7 · Cited by 97
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
Gao, H., Jiang, Y., Zeng, G., Huda, N., Thoudam, T., Yang, Z., Liangpunsakul, S., & Ma, J. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100104 · Cited by 87
Metadata
- Authors
- Mackowiak, B., Fu, Y., Maccioni, L., & Gao, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Gao, Bin
- Venue
- Journal of Clinical Investigation
- Published
- 2024-02-01
- Volume
- 134
- Issue
- 3
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10836812
- OpenAlex
- W4391540982
- Cited by
- 359
- References
- 202
- Citations by year
- 2026: 129 · 2025: 160 · 2024: 70
- FWCI
- 26.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- alcoholic liver disease, alcoholic steatohepatitis, alcoholic cirrhosis, pathogenesis, therapeutic target, multi-omics, preclinical models, metabolic dysfunction, disease heterogeneity, translational research
- MeSH terms
- Ethanol, Fatty Liver, Carcinoma, Hepatocellular, Humans, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.